Sign in

Uveitis National Clinical Study Group

@uveitiscsg.bsky.social
62 followers 61 following 28 posts

The Uveitis Clinical Study Group is a UK-based organisation set up by clinicians to support clinical research in uveitis and scleritis throughout the UK. www.uveitisstudygroup.org

PostsRepliesMedia
Reposted by Uveitis National Clinical Study Group
Medical Ophthalmology Society UK @mosuknews.bsky.social · 02/10/2026
👁️ Join us at MOSUK 2027 to explore the eye-systemic axis! 📍 London | 24 Feb Giant Cell Arteritis • Pregnancy & the eye • Sickle cell retinopathy 🏆 Abstracts due 8 Jan, compete for a national prize! UKNOS follows on 25 Feb at the same venue. www.mosuk.co.uk
022
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 13/09/2026
The Multimodal Imaging in Uveitis (MUV) Taskforce has published Report 15: Evidence and Consensus-Based Imaging Guidelines in Cytomegalovirus Retinitis, now available in Ophthalmology Retina. www.ophthalmologyretina.org/article/S246... #Uveitis #Retina #CMV
122
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 11/09/2026
🇮🇹 Join IUSG’s Global Case Conference 7: representative uveitis cases from Italy! 📅 Sat 12 Sept 🕐 13:00–14:30 BST | 14:00–15:30 CEST Un’occasione per imparare insieme! 🔗 Register here: zoom.us/webinar/regi... #Uveitis #Ophthalmology
021
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 30/08/2026
📢 Help shape UK-wide biologic pathways for ocular inflammatory disease. The Uveitis CSG’s Delphi project covers children and adults, starting with tocilizumab for refractory non-infectious uveitis. Get involved: uveitisstudygroup.org
022
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 30/07/2026
👁️🔬 The July NIHR UK Uveitis Clinical Study Group newsletter ⬇️ Our mission: to enable every eligible patient to participate in ocular inflammation trials and studies across the UK and Ireland. www.uveitisstudygroup.org #Uveitis #Ophthalmology #ClinicalTrials #EyeResearch #NIHR
112
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 29/07/2026
📅 Save the date: 4 December 2026 Join Moorfields Education for "Hypotony: Diagnosis and Management - From Theory to Practice": expert case discussions, hands-on B-scan/UBM workshops, patient perspectives and multidisciplinary learning. Book: checkout.moorfields.nhs.uk/product?cata...
000
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 14/07/2026
A lesson from #ISU2026: progress in #uveitis does not happen in silos. Countries see different disease patterns, and no single specialty owns ocular inflammation. Constructive disagreement is where collaboration begins. Some reflections: www.linkedin.com/posts/nimagh...
linkedin.com
#uveitis #isu2026 #genetics #immunology #ai #therapeutics #whitedotsyndromes #vasculitis #microbiome #oncology #ophthalmology | Nima Ghadiri
From nuclein to new definitions: lessons from Tübingen about the future of #uveitis 🧬👁️:- In 1869, in a laboratory within Tübingen Castle, Friedrich Miescher isolated a previously unknown substance f...
122
Reposted by Uveitis National Clinical Study Group
@vasculitides @vasculitides.bsky.social · 11/07/2026
Safety and Efficacy of Adalimumab in the Treatment of Refractory Behcet's Uveitis: A Prospective Cohort Study
pubmed.ncbi.nlm.nih.gov
Safety and Efficacy of Adalimumab in the Treatment of Refractory Behçet's Uveitis: A Prospective Cohort Study - PubMed
Adalimumab demonstrated significant efficacy in controlling ocular and systemic inflammation in refractory Behçet's uveitis with a meaningful steroid-sparing effect and acceptable safety profile over ...
011
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 08/07/2026
Last week’s Joint Uveitis NW Meeting at the Whitworth Art Gallery brought Liverpool & Manchester together beneath the waves, rain and landscapes of Hokusai and Hiroshige. #Uveitis, like art, is about layers, pattern recognition and seeing what lies beneath... www.linkedin.com/posts/nimagh...
linkedin.com
#electrodiagnostics #inflammation #uveitis | Nima Ghadiri
𝐕𝐢𝐬𝐢𝐨𝐧𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐅𝐥𝐨𝐚𝐭𝐢𝐧𝐠 𝐖𝐨𝐫𝐥𝐝: 𝐑𝐞𝐟𝐥𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐨𝐧 𝐈𝐧𝐟𝐥𝐚𝐦𝐦𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐋𝐚𝐲𝐞𝐫𝐬 🌊🎨 Last week, the Uveitis communities of Liverpool and Manchester converged once again The Whitworth Gallery for our J...
122
Reposted by Uveitis National Clinical Study Group
@vasculitides @vasculitides.bsky.social · 08/07/2026
Sex Differences in Uveitis Etiology: A Systematic Review and Meta-Analysis
pubmed.ncbi.nlm.nih.gov
Sex Differences in Uveitis Etiology: A Systematic Review and Meta-Analysis - PubMed
Sex-related differences were observed within the included specialist cohorts. Autoimmune-associated uveitis was relatively more frequent among females, whereas HLA-B27-associated and certain infectiou...
011
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 02/07/2026
The first CHOIR Community webinar takes place tonight at 7pm BST 🎉 This is a new space for children, young people & families affected by rare childhood-onset inflammatory eye conditions. Register: ucl.zoom.us/webinar/regi... choir-lab.com #CHOIR #Uveitis #Ophthalmology @lolaeyedoc.bsky.social
043
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 29/06/2026
Time to retire “White Dot Syndromes”. Modern multimodal imaging shows these are distinct inflammatory chorioretinal diseases - with different biology, prognosis & treatment. Precision in language = precision in care. #Uveitis #WhiteDotSyndromes #Retina #MUV @uveitissociety.bsky.social
022
Reposted by Uveitis National Clinical Study Group
Ophthopedia @ophthalmology.bsky.social · 18/06/2026
Ophthopedia Update: Outcomes of Upadacitinib Use in Non-Infectious Uveitis: Novel Report of 12 Cases and Summary of Published Reports: .
dlvr.it
Outcomes of Upadacitinib Use in Non-Infectious Uveitis: Novel Report of 12 Cases and Summary of Published Reports
.
011
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 23/06/2026
The eye is not an isolated organ - it's a window into systemic health and a meeting point for #oralmedicine, #infectiousdiseases, #immunology, #sexualhealth, #neurology, #rheumatology and many other specialities. This year I had a busy 4-day conference journey.. www.linkedin.com/posts/nimagh...
linkedin.com
#bisom #oralmedicine #behçet #sarcoidosis #pemphigoid #bhiva #bashh #infectiousdiseases #immunology #sexualhealth #neurology #medicine #bsr #uveitis #axialspa #rheumatology #ophthalmology #sharedcare…...
𝐁𝐫𝐢𝐝𝐠𝐢𝐧𝐠 𝐭𝐡𝐞 𝐄𝐲𝐞-𝐒𝐲𝐬𝐭𝐞𝐦𝐢𝐜 𝐀𝐱𝐢𝐬: The eye isn’t an isolated organ - it’s a profound window into systemic health and a crossroads where multiple medical specialties meet. As ophthalmic physicians, we ha...
133
Reposted by Uveitis National Clinical Study Group
Ophthopedia @ophthalmology.bsky.social · 23/06/2026
Ophthopedia Update: Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis: Idiopathic uveitis comprises a heterogeneous group of intraocular inflammatory diseases that are often immune-mediated and can lead to significant… #Ophthalmology #Ophthotwitter #Scicomm
dlvr.it
Associations Between Routine Vaccinations and the Risk of New-Onset Idiopathic Uveitis
Idiopathic uveitis comprises a heterogeneous group of intraocular inflammatory diseases that are often immune-mediated and can lead to significant visual morbidity.1 Although the precise triggers remain unclear in many cases, systemic immune activation following viral infections is recognized as a potential contributor to the onset or exacerbation of ocular inflammation through mechanisms such as molecular mimicry, bystander activation, and disruption of ocular immune privilege.1–3 Viral infections can also compromise the blood-retina barrier and alter local immune regulation, reducing tolerance to self-antigens and promoting a proinflammatory milieu.
011
Reposted by Uveitis National Clinical Study Group
Ophthopedia @ophthalmology.bsky.social · 29/05/2026
Ophthopedia Update: Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies: Eye, Published online: 29 May 2026; doi:10.1038/s41433-026-04460-xClinical outcomes of… #Ophthalmology #Eye #Ophthotwitter
dlvr.it
Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies
Eye, Published online: 29 May 2026; doi:10.1038/s41433-026-04460-xClinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies
021
Reposted by Uveitis National Clinical Study Group
Dr. John Cush @rheumnow.bsky.social · 26/04/2026
Comorbidity burden, uveitis, & psoriasis independently assoc w/ greater spinal radiographic progression in AS. Study3,441 pts (75% male; 84% B27+). Progression greater w/ 2+ comorbidities & uveitis, & PSO buff.ly/8jOxNUr
021
Reposted by Uveitis National Clinical Study Group
brandon-beaber.bsky.social @brandon-beaber.bsky.social · 27/04/2026
According to this study from Finland, 6% of people with multiple sclerosis also have uveitis, but the majority (about 2/3rds) are undiagnosed, many of whom had no ocular symptoms when evaluated by a uveitis specialist for the study. pubmed.ncbi.nlm.nih.gov/42030885/
pubmed.ncbi.nlm.nih.gov
Checking your browser - reCAPTCHA
031
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 05/05/2026
🚨 HEALTH ALERT: Do you prep raw seafood at home? A newly reported eye condition, POH-VAU, has been linked to CMNV, a virus found in aquatic animals including shrimp/fish which has jumped to humans This is a treatment-resistant eye disease leading to vision loss, & 70 cases have been identified.
122
Reposted by Uveitis National Clinical Study Group
Springer Medicine @springermedicine.com · 30/04/2026
#MedNews - #Vamikibart is well tolerated and improves best-corrected visual acuity and central subfield thickness in people with uveitic macular edema secondary to noninfectious #uveitis. 👉️ buff.ly/4SdBpgM #EyeSky
springermedicine.com
Early data support vamikibart for uveitic macular edema
Vamikibart is well tolerated and improves best-corrected visual acuity and central subfield thickness in people with uveitic macular edema secondary to noninfectious uveitis.
022
Reposted by Uveitis National Clinical Study Group
UCL Discovery @ucldiscovery.bsky.social · 01/05/2026
Open Access UCL Research: Defining the role of B cells in the pathogenesis of juvenile idiopathic arthritis-associated uveitis discovery.ucl.ac.uk/id/eprint/10...
discovery.ucl.ac.uk
Defining the role of B cells in the pathogenesis of juvenile idiopathic arthritis-associated uveitis. - UCL Discovery
UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
022
Reposted by Uveitis National Clinical Study Group
UCL Discovery @ucldiscovery.bsky.social · 28/04/2026
Open Access UCL Research: Monitoring of Juvenile Idiopathic Arthritis–Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveitis in Childhood discovery.ucl.ac.uk/id/eprint/10...
discovery.ucl.ac.uk
Monitoring of Juvenile Idiopathic Arthritis–Associated Uveitis in Long-Term Disease Remission: Consensus-Based Recommendations From the Multinational Interdisciplinary Working Group for Uveiti...
UCL Discovery is UCL's open access repository, showcasing and providing access to UCL research outputs from all UCL disciplines.
011
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 28/04/2026
The uveitis gang at #BSR2026: delighted to join my friend @uveitisharry speaking to rheumatology residents and fellows about spondyloarthritis + eye disease These conditions sit firmly at the eye-systemic axis, & patients benefit most when ophthalmologists and rheumatologists work closely together
131
Reposted by Uveitis National Clinical Study Group
JAMA Ophthalmology @jamaophthalmology.bsky.social · 09/04/2026
Intravitreal vamikibart was tolerated and associated with improved visual acuity and reduced macular thickness over 12 weeks in a phase 1 trial for uveitic macular edema secondary to noninfectious uveitis. jamanetwork.com/journals/jam...
Figure 2. Line graphs show Best-Corrected Visual Acuity(BCVA) outcomes. Graph A shows BCVA in study eye; Graph B shows change in BCVA in study eye. Each graph plots data for 0.25mg@1, 1mg@2, 2.5mg@3, and all participants@4 over time.
011
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 14/04/2026
We’re delighted to announce a new special section in Eye @natureportfolio.nature.com on Thyroid Eye Disease & Orbital Inflammation. This is a timely moment: clinical trials, translational science + targeted therapies are reshaping how we think about these diseases. nature.com/eye eye@rcophth.ac.uk
121
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 10/04/2026
World Uveitis Day shines a light on a sight-threatening, often overlooked group of diseases linked to systemic inflammation. Raising awareness means earlier diagnosis, better care, and preventing avoidable blindness. Find out more here: worlduveitisday.org #Uveitis
031
Reposted by Uveitis National Clinical Study Group
Medical Ophthalmology Society UK @mosuknews.bsky.social · 16/03/2026
👩🏻‍🤝‍👩🏼 Celebrating our sister society @UKNOSoc MOSUK was delighted to support this year’s UKNOS meeting at RCP Spaces on 26–27 Feb 2026. A fantastic programme focused on inflammatory disease at the eye-brain interface, with neuro-#ophthalmology, #neurology and allied professionals bit.ly/4sNzDOE
bit.ly
#ophthalmology #neurology #multiplesclerosis #mogad #uveitis #sarcoidosis #behçet | Medical Ophthalmology Society UK (MOSUK)
👩🏻‍🤝‍👩🏼 Celebrating our Sister Society: UKNOS 2026 👁️🧠 MOSUK was delighted to support and celebrate this year’s UKNOS - The UK Neuro-Ophthalmology Society meeting, held on 26-27 Feb 2026 at RCP Space...
132
Reposted by Uveitis National Clinical Study Group
Fight for Sight @fightforsight.bsky.social · 13/03/2026
#Glaucoma affects 80 million people worldwide, set to rise to 120 million by 2040. We’re supporting Dr Ben Mead’s research into exosomes—tiny cell messengers that could help slow retinal cell loss in glaucoma. Advancing research is key to saving sight. Read more: ow.ly/ZXSa50YrLOM
Portrait of Dr. Ben Mead in a brown sweater with a quote about glaucoma's slow progression and potential for reversal by Dr. Ben Mead from Cardiff University on a blue background.
012
Reposted by Uveitis National Clinical Study Group
Medical Ophthalmology Society UK @mosuknews.bsky.social · 03/03/2026
What a fantastic day at the 27th Annual Medical Ophthalmology Society UK (MOSUK) meeting! Hosted at the striking @RCPspaces in Liverpool on Feb 25th, 2026, this day celebrates the Eye-Systemic Axis. Hosted by Dr Greg Heath & @drnimaghadiri.bsky.social www.linkedin.com/posts/medica...
linkedin.com
#iih #headache #mosuk #diabetes #diabeticretinopathy #machinelearning #behçet #rheumatology | Medical Ophthalmology Society UK (MOSUK)
MOSUK Annual Meeting 2026 On the 25th February, Medical Ophthalmology Society UK (MOSUK) gathered for a highly successful 27th annual meeting at the striking RCP Spaces at The Spine in Liverpool. Hos...
132
Reposted by Uveitis National Clinical Study Group
ACR Journals @acr-journals.bsky.social · 21/02/2026
New studies posted this week in Arthritis & Rheumatology: Adalimumab ± MTX as first-line therapy for childhood-onset chronic uveitis doi.org/10.1002/art.... Bisphosphonates & PPI/H2RA coprescriptions in polymyalgia rheumatica doi.org/10.1002/art....
Weekly recap in ACR Journals - Arthritis & Rheumatology cover
122
Reposted by Uveitis National Clinical Study Group
@vasculitides @vasculitides.bsky.social · 24/02/2026
Combination of Methotrexate and Mycophenolate mofetil for Refractory Uveitis & Scleritis: A Case Series
pubmed.ncbi.nlm.nih.gov
Combination of Methotrexate and Mycophenolate mofetil for Refractory Uveitis & Scleritis: A Case Series - PubMed
The combination of oral methotrexate and mycophenolate mofetil can be a useful alternative in patients resistant to conventional immunosuppression.
011
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 12/02/2026
It’s never Lupus… or is it? 🐺 Last month we had a fantastic #Uveitis NW meeting at RCP Spaces at the Spine, highlighting why collaboration between specialities is vital, taking lessons from House MD about avoiding anchoring & spotting masquerades. #Ophthalmology #Rheumatology
132
Reposted by Uveitis National Clinical Study Group
Fight for Sight @fightforsight.bsky.social · 03/02/2026
Research published in Nature sheds new light on uveitis – a painful, sight-threatening condition linked to arthritis. Proud to have funded the PhD studentship of senior author Dr Lizzy Rosser. ow.ly/1q2n50Y8130
A picture of veteran fundraiser Elizabeth Maxwell, who lost her vision due to a condition linked to childhood arthritis. Elizabeth has white hair and is pictured at home in a bright red blouse and a blue scarf.
031
Reposted by Uveitis National Clinical Study Group
Waggoner Lab @labwaggoner.bsky.social · 03/02/2026
Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis @nature.com www.nature.com/articles/s41...
072
Reposted by Uveitis National Clinical Study Group
Lizzy Rosser @bcellsrosser.bsky.social · 03/02/2026
Very proud that our investigating uveitis pathogenesis in young people living with arthritis is out today @natcomms.nature.com. A real team science effort made possible by collaborations across hospital & researchers with support of patients. Check it out 👇 www.nature.com/articles/s41...
nature.com
Altered B cell activation contributes to the immunopathogenesis of childhood arthritis-associated uveitis - Nature Communications
Juvenile idiopathic arthritis (JIA) associated uveitis can cause vision loss in children, but mechanisms remain unclear. The authors here identify elevated CD19+IgD-CD27- double negative type 1 B cell...
3164
Reposted by Uveitis National Clinical Study Group
Fight for Sight @fightforsight.bsky.social · 09/02/2026
Researchers from UCL and Moorfields Eye Hospital NHS have made a significant contribution to our understanding of uveitis and recently shared their findings in Nature Communications. Read about the study here: ow.ly/8HOX50YbK62 #Research #Uveitis #MedicalResearch
022
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 22/01/2026
Looking forward to our pack of North-West residents and fellows gathering to sharpen our diagnostic senses, as we track down the oculo-systemic manifestations of Lupus next week #Uveitis #Lupus 🌕🐺
062
Reposted by Uveitis National Clinical Study Group
Journal of the American Veterinary Medical Association (JAVMA) @avmajavma.bsky.social · 16/01/2026
Resolution of uveitis during antiviral treatment does not confirm FIP. Comprehensive diagnostic evaluation is essential to avoid misdiagnosis and inappropriate treatment. Open access article: jav.ma/uveitiscat
021
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 15/12/2025
Join us for “Steroids in Inflammatory Eye Disease: Friend or Foe?” and put your questions directly to the experts. Featuring: Professor Ann Morgan Miss Kanchan Bhan (Chair) 📅 17 December 2025 ⏰ 4–5pm 💻 Online 🔗 Register via link / QR code #uveitis #ophthalmology #inflammation #eyecare #scleritis
032
Reposted by Uveitis National Clinical Study Group
Genes & Diseases Journal @genesndiseases.bsky.social · 07/12/2025
IFN-λs suppress autoreactive Th1 & Th17 cell responses, promote #Treg expansion, and regulate NLRP1/NLRP3 signaling to preserve BRB integrity and attenuate #OcularInflammation in experimental #Autoimmune #uveitis. #medsky #OpenAccess: doi.org/10.1016/j.ge...
041
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 10/12/2025
👁️ MOSUK 2026: Where Systemic Meets Sight Join us in Liverpool for a dedication to cross-specialty collaboration 📅 25 Feb 2026 |📍The Spine, Liverpool 🔗 Register & Info www.mosuk.co.uk #Ophthalmology #MedEd #MOSUK2026 As seen in Eye News: cloud.3dissue.net/30176/30071/...
132
Reposted by Uveitis National Clinical Study Group
Ophthopedia @ophthalmology.bsky.social · 10/12/2025
Ophthopedia Update: Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial: .
dlvr.it
Six-Month Versus Nine-Month Anti-Tubercular Therapy for Tubercular Posterior Uveitis: A Multicenter, Randomized Controlled Trial
.
011
Reposted by Uveitis National Clinical Study Group
Ophthopedia @ophthalmology.bsky.social · 18/11/2025
Ophthopedia Update: Clinical Significance of T-SPOT.TB Test in Patients with Uveitis in South Korea: Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), remains one of the major causes of mortality and morbidity worldwide.1 In 2023,… #Ophthalmology #Ophthotwitter #Scicomm
dlvr.it
Clinical Significance of T-SPOT.TB Test in Patients with Uveitis in South Korea
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), remains one of the major causes of mortality and morbidity worldwide.1 In 2023, South Korea reported an annual TB incidence rate of 38.2 per 100,000 population, the second highest among countries in the Organization for Economic Co-operation and Development and is considered an intermediate-burden country for TB.2-4 Following exposure to M. tuberculosis, approximately 90% of individuals develop latent TB infection (LTBI), a condition defined by a sustained immune response to TB antigens without clinical or microbiological evidence of active disease.
022
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 19/11/2025
From uveitis to scleritis to GCA, ocular clues often reveal hidden rheumatic disease. In our"Talking Rheumatology" episode we highlight how teamwork between #ophthalmology & #rheumatology saves sight AND diagnoses Apple: podcasts.apple.com/us/podcast/t... Spotify: open.spotify.com/show/0kygBQZ...
podcasts.apple.com
Talking Rheumatology Spotlight
Medicine Podcast · Updated Daily · Explore rheumatological conditions with the clinical experts. This monthly podcast covers everything from disease presentation to diagnosis, treatment and management...
133
Reposted by Uveitis National Clinical Study Group
ACR Journals @acr-journals.bsky.social · 27/07/2024
A new study of JIA-associated uveitis identifies 3 genetic markers within the MHC associated with susceptibility to uveitis. Integration of the genetic markers with clinical risk factors improves the risk prediction of JIA uveitis In A&R loom.ly/kyx-e38 🩺
Figure 1: Manhattan plots for independent associations within the HLA region. (A) Position 11 of HLA-DRB1 is lead marker for HLA association analysis. (B) HLA-A SNP rs2523765 is lead marker for conditional analysis of position 11 of HLA-DRB1. (C) HLA-DPB1*0201 is lead marker for conditional analysis of position 11 of DRB1 and rs2523765. (D) Conditional analysis of three leading HLA markers finds no further study-wide significant markers. The log10 of the p-value of each HLA marker (vertical axis) is plotted against the base position of each HLA marker on chromosome 6.
011
Reposted by Uveitis National Clinical Study Group
Betty C. Jung @bettycjung.bsky.social · 30/10/2025
What Is Uveitis? jamanetwork.com/journals/jam...
jamanetwork.com
Patient Information: Uveitis
This JAMA Patient Page describes types of uveitis, ages and conditions associated with uveitis, and diagnosis and treatment.
141
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 30/10/2025
In Harmonious Orbit-When Physicians & Surgeons Align At Aintree Hospital @nhsuhlg.bsky.social our joint clinic unites physicians and surgeons to manage complex orbital inflammation & #thyroideyedisease A joint approach means rapid decisions, holistic care & optimal patient outcomes #Ophthalmology
232
Reposted by Uveitis National Clinical Study Group
Dr Nima Ghadiri - FBNHS @drnimaghadiri.bsky.social · 29/09/2025
📢 Childhood Onset Uveitis Info Day (UNICORNS Group) 🦄 📅 Sun 5 Oct 2025 | ⏰ 10:00–16:00 BST 📍 Weston House, Great Ormond St, London + Online Join for expert talks & support on childhood #uveitis @lolaeyedoc.bsky.social Unicorns: www.ucl.ac.uk/population-h... www.eventbrite.com/e/childhood-...
ucl.ac.uk
UNICORNS
Uveitis in childhood prospective national cohort study
023
Reposted by Uveitis National Clinical Study Group
NIHR Biomedical Research Centre: Moorfields @moorfieldsbrc.bsky.social · 14/05/2025
Dr Colin Chu secures Moorfields Charity grant to improve the diagnosis of uveitis using cutting-edge metagenomics technology. By capturing the previously undetectable causes, this research could deliver new diagnoses & treatment. 🔗 buff.ly/oPF7GV @ucleye.bsky.social @colinchulab.bsky.social
Graphic featuring a quote by Dr Colin Chu: “This research project will help us to bring metagenomic sequencing to a wider range of patients with uveitis, that could provide new diagnoses and treatment options, alongside increasing our fundamental understanding of inflammation in the eye.” There is a blue background with colourful icons and the NIHR Moorfields BRC logo.
031
Uveitis National Clinical Study Group @uveitiscsg.bsky.social · 24/07/2025
We hope this was useful for patients and carers, watch this space for the next webinar!
010